Wolverine Trading’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Hold |
0
| – | – | – | 2592 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 2563 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 2411 |
|
2024
Q2 | – | Sell |
-13,931
| Closed | -$68.5K | – | 2339 |
|
2024
Q1 | $68.5K | Buy |
+13,931
| New | +$68.5K | ﹤0.01% | 1081 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 2332 |
|
2023
Q3 | – | Sell |
-19,346
| Closed | -$478K | – | 2296 |
|
2023
Q2 | $478K | Sell |
19,346
-2,887
| -13% | -$71.3K | ﹤0.01% | 546 |
|
2023
Q1 | $692K | Buy |
22,233
+8,386
| +61% | +$261K | ﹤0.01% | 404 |
|
2022
Q4 | $256K | Buy |
13,847
+3,556
| +35% | +$65.7K | ﹤0.01% | 664 |
|
2022
Q3 | $264K | Buy |
+10,291
| New | +$264K | ﹤0.01% | 787 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 2534 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 2765 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 2857 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 2842 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2751 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2617 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 2283 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 2145 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 2167 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 2169 |
|
2019
Q4 | – | Sell |
-13,996
| Closed | -$193K | – | 2106 |
|
2019
Q3 | $193K | Sell |
13,996
-5,268
| -27% | -$72.6K | ﹤0.01% | 1056 |
|
2019
Q2 | $250K | Buy |
+19,264
| New | +$250K | ﹤0.01% | 871 |
|
2019
Q1 | – | Sell |
-17,642
| Closed | -$342K | – | 2168 |
|
2018
Q4 | $342K | Buy |
17,642
+3,499
| +25% | +$67.8K | ﹤0.01% | 800 |
|
2018
Q3 | $351K | Buy |
+14,143
| New | +$351K | ﹤0.01% | 976 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 2000 |
|
2018
Q1 | – | Sell |
-14,237
| Closed | -$509K | – | 2298 |
|
2017
Q4 | $509K | Buy |
+14,237
| New | +$509K | ﹤0.01% | 885 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 2060 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 2045 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 2109 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 2176 |
|